ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

NASDAQ:Z • US98954M2008

42.83 USD
-2.63 (-5.79%)
At close: Feb 23, 2026
42.4231 USD
-0.41 (-0.95%)
After Hours: 2/23/2026, 4:30:02 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to Z. Z was compared to 62 industry peers in the Real Estate Management & Development industry. No worries on liquidiy or solvency for Z as it has an excellent financial health rating, but there are worries on the profitability. Z has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • Z had positive earnings in the past year.
  • In the past year Z had a positive cash flow from operations.
  • In the past 5 years Z reported 4 times negative net income.
  • Of the past 5 years Z 4 years had a positive operating cash flow.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

1.2 Ratios

  • Z's Return On Assets of 0.40% is in line compared to the rest of the industry. Z outperforms 53.23% of its industry peers.
  • Z has a Return On Equity (0.47%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.4%
ROE 0.47%
ROIC N/A
ROA(3y)-1.3%
ROA(5y)-2.07%
ROE(3y)-1.78%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8

1.3 Margins

  • The Profit Margin of Z (0.89%) is comparable to the rest of the industry.
  • Z has a better Gross Margin (74.14%) than 88.71% of its industry peers.
  • In the last couple of years the Gross Margin of Z has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 0.89%
GM 74.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y9.35%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

  • Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, Z has less shares outstanding
  • Compared to 5 years ago, Z has about the same amount of shares outstanding.
  • The debt/assets ratio for Z has been reduced compared to a year ago.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • Z has an Altman-Z score of 8.52. This indicates that Z is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 8.52, Z belongs to the best of the industry, outperforming 88.71% of the companies in the same industry.
  • Z has a debt to FCF ratio of 3.60. This is a good value and a sign of high solvency as Z would need 3.60 years to pay back of all of its debts.
  • Z has a better Debt to FCF ratio (3.60) than 74.19% of its industry peers.
  • Z has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.07, Z is doing good in the industry, outperforming 75.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.6
Altman-Z 8.52
ROIC/WACCN/A
WACC8.48%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

2.3 Liquidity

  • Z has a Current Ratio of 3.13. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of Z (3.13) is better than 75.81% of its industry peers.
  • Z has a Quick Ratio of 3.13. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
  • Z has a Quick ratio of 3.13. This is in the better half of the industry: Z outperforms 79.03% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 19.71% over the past year.
  • Measured over the past years, Z shows a very strong growth in Earnings Per Share. The EPS has been growing by 35.43% on average per year.
  • Looking at the last year, Z shows a quite strong growth in Revenue. The Revenue has grown by 15.52% in the last year.
  • The Revenue has been decreasing by -5.01% on average over the past years.
EPS 1Y (TTM)19.71%
EPS 3Y1.9%
EPS 5Y35.43%
EPS Q2Q%44.44%
Revenue 1Y (TTM)15.52%
Revenue growth 3Y9.67%
Revenue growth 5Y-5.01%
Sales Q2Q%18.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 33.55% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.61% on average over the next years. This is quite good.
EPS Next Y37.18%
EPS Next 2Y34.86%
EPS Next 3Y39.87%
EPS Next 5Y33.55%
Revenue Next Year15.62%
Revenue Next 2Y14.43%
Revenue Next 3Y13.67%
Revenue Next 5Y13.61%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 26.12, which means the current valuation is very expensive for Z.
  • Z's Price/Earnings ratio is a bit cheaper when compared to the industry. Z is cheaper than 67.74% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.99. Z is around the same levels.
  • The Price/Forward Earnings ratio is 19.04, which indicates a rather expensive current valuation of Z.
  • Based on the Price/Forward Earnings ratio, Z is valued a bit cheaper than 79.03% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.02. Z is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 26.12
Fwd PE 19.04
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as Z.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as Z.
Industry RankSector Rank
P/FCF 102.64
EV/EBITDA 39.58
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • Z's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • Z's earnings are expected to grow with 39.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.7
PEG (5Y)0.74
EPS Next 2Y34.86%
EPS Next 3Y39.87%

0

5. Dividend

5.1 Amount

  • Z does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ZILLOW GROUP INC - C

NASDAQ:Z (2/23/2026, 4:30:02 PM)

After market: 42.4231 -0.41 (-0.95%)

42.83

-2.63 (-5.79%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-10
Earnings (Next)05-05
Inst Owners99.3%
Inst Owner Change-0.27%
Ins Owners6.41%
Ins Owner Change2.04%
Market Cap10.37B
Revenue(TTM)2.58B
Net Income(TTM)23.00M
Analysts74.67
Price Target88.49 (106.61%)
Short Float %5.87%
Short Ratio2.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.12%
Min EPS beat(2)-4.41%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-0.76%
Min EPS beat(4)-7.26%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)6.73%
EPS beat(12)9
Avg EPS beat(12)38.85%
EPS beat(16)13
Avg EPS beat(16)84.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-1.43%
Max Revenue beat(4)-0.3%
Revenue beat(8)3
Avg Revenue beat(8)0.61%
Revenue beat(12)7
Avg Revenue beat(12)1.87%
Revenue beat(16)9
Avg Revenue beat(16)-6.6%
PT rev (1m)0.23%
PT rev (3m)-2.41%
EPS NQ rev (1m)-5.49%
EPS NQ rev (3m)-4.98%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)1.98%
Revenue NQ rev (3m)2.02%
Revenue NY rev (1m)1.06%
Revenue NY rev (3m)1.37%
Valuation
Industry RankSector Rank
PE 26.12
Fwd PE 19.04
P/S 4.01
P/FCF 102.64
P/OCF 28.17
P/B 2.12
P/tB 5.82
EV/EBITDA 39.58
EPS(TTM)1.64
EY3.83%
EPS(NY)2.25
Fwd EY5.25%
FCF(TTM)0.42
FCFY0.97%
OCF(TTM)1.52
OCFY3.55%
SpS10.67
BVpS20.18
TBVpS7.36
PEG (NY)0.7
PEG (5Y)0.74
Graham Number27.29
Profitability
Industry RankSector Rank
ROA 0.4%
ROE 0.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.89%
GM 74.14%
FCFM 3.91%
ROA(3y)-1.3%
ROA(5y)-2.07%
ROE(3y)-1.78%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y9.35%
F-Score8
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.6
Debt/EBITDA 1.57
Cap/Depr 101.14%
Cap/Sales 10.34%
Interest Coverage N/A
Cash Conversion 158.62%
Profit Quality 439.13%
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 8.52
F-Score8
WACC8.48%
ROIC/WACCN/A
Cap/Depr(3y)81.29%
Cap/Depr(5y)78.02%
Cap/Sales(3y)8.82%
Cap/Sales(5y)6.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.71%
EPS 3Y1.9%
EPS 5Y35.43%
EPS Q2Q%44.44%
EPS Next Y37.18%
EPS Next 2Y34.86%
EPS Next 3Y39.87%
EPS Next 5Y33.55%
Revenue 1Y (TTM)15.52%
Revenue growth 3Y9.67%
Revenue growth 5Y-5.01%
Sales Q2Q%18.05%
Revenue Next Year15.62%
Revenue Next 2Y14.43%
Revenue Next 3Y13.67%
Revenue Next 5Y13.61%
EBIT growth 1Y83.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1915.73%
EBIT Next 3Y215.92%
EBIT Next 5Y113.16%
FCF growth 1Y-60.7%
FCF growth 3Y-71.5%
FCF growth 5Y-20.38%
OCF growth 1Y-14.02%
OCF growth 3Y-56.61%
OCF growth 5Y-2.8%

ZILLOW GROUP INC - C / Z FAQ

What is the ChartMill fundamental rating of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a fundamental rating of 5 / 10 to Z.


What is the valuation status of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a valuation rating of 5 / 10 to ZILLOW GROUP INC - C (Z). This can be considered as Fairly Valued.


What is the profitability of Z stock?

ZILLOW GROUP INC - C (Z) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for Z stock?

The Price/Earnings (PE) ratio for ZILLOW GROUP INC - C (Z) is 26.12 and the Price/Book (PB) ratio is 2.12.


What is the financial health of ZILLOW GROUP INC - C (Z) stock?

The financial health rating of ZILLOW GROUP INC - C (Z) is 8 / 10.